Leukotrap – CP2D Solution (Haemonetics Manufacturing Inc)
Welcome to the PulseAid listing for the Leukotrap – CP2D Solution drug offered from Haemonetics Manufacturing Inc. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Haemonetics Manufacturing Inc |
NON-PROPRIETARY NAME: | Anticoagulant Citrate Phosphate Double Dextrose |
SUBSTANCE NAME: | DEXTROSE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1983-11-09 |
END MARKETING DATE: | 0000-00-00 |
Leukotrap – CP2D Solution HUMAN PRESCRIPTION DRUG Details:
Item Description | Leukotrap – CP2D Solution from Haemonetics Manufacturing Inc |
LABELER NAME: | Haemonetics Manufacturing Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 3.57(g/70mL) |
START MARKETING DATE: | 1983-11-09 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 53157-123_1fe72177-6c12-4e3f-8895-b9d3ba994d9b |
PRODUCT NDC: | 53157-123 |
APPLICATION NUMBER: | NDA820915 |
Other DEXTROSE Pharmaceutical Manufacturers / Labelers: